A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
about
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsisBeta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaBeta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsisBeta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaReview of the pharmacology, pharmacokinetics, and clinical use of cephalosporinsCost-effectiveness of ceftazidime or imipenem/cilastatin versus ceftriaxone + aminoglycoside in the treatment of febrile episodes in neutropenic cancer patients in Germany.Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.Imipenem-cilastatin as initial therapy for febrile cancer patientsVancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.Combination therapy for treatment of infections with gram-negative bacteria.Pseudomonas aeruginosa infection in cancer patients.Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.Controversies in the management of febrile neutropenic cancer patients.Antimicrobial activity, pharmacokinetics, therapeutic indications and adverse reactions of ceftazidime.A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patients.Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.Single agent therapy for infections in cancer patients: a prospective randomized trial comparing three extended-spectrum cephalosporins.In vitro activity of FK-037, a novel parenteral cephalosporin, against bacterial isolates from neutropenic cancer patients.
P2860
Q24201201-C3598ED0-AF7B-4E65-90FF-CCD1557EA425Q24201767-574B78FD-47E9-4EA0-9188-D96ADDCE1B76Q24244685-6E0C208E-1B7C-4E07-BDD9-E4ACB6137BD0Q24248048-0057D8CE-287C-4BAC-9507-D97EC4CA8DE6Q24616317-DDCA67B2-0173-402A-B2CE-38F4448CCB1BQ33535030-138269A2-81FE-4F07-9914-561FAB2AD8E4Q35136181-C0A97B98-6967-49A8-A281-1C98C5248202Q35536384-C632A95E-BDE6-4583-9803-E57C982F251AQ35540674-98F8212B-AF47-41B0-9661-96D15845F329Q35651131-952B18F4-99D1-49BC-B34F-8239097AA133Q35836302-465C1B33-50F8-4813-84F5-842D21D9FBB9Q36156077-DB04B762-A059-4314-86E2-6860BF66F503Q36756527-9175CA5B-21AF-409D-9C66-2FF6B584FFA9Q39261281-C80DDC17-3D54-483B-A7CF-4FC4B9511F12Q39603225-B149EF2B-DEFE-46F0-85C0-28AD78424BA4Q39835738-5A6B1AD8-4896-4801-8E79-F0A45A7301DFQ40596325-E4C6EAED-0A29-402D-A263-6045DF2BD896Q40605985-0CB831DA-1816-49CA-9AB0-C8CFFD629628Q40665340-D8F2C0CB-9712-48AF-A9CB-81C780D07614Q40678015-E94787A5-4C12-47C0-AFD3-624A4C920E45Q40747021-C1F2DF96-ABCE-4A5D-9F72-BA16A6AB696AQ40787432-9C220CCA-0A70-44E5-A44E-098D39E0AB5CQ43636403-0A01D9D1-D18E-4608-A39E-5FC3A3521D51Q54199061-89C946D5-AB16-42FB-924E-01E2B2BF8967
P2860
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
A randomized study of ceftazid ...... infections in cancer patients.
@en
type
label
A randomized study of ceftazid ...... infections in cancer patients.
@en
prefLabel
A randomized study of ceftazid ...... infections in cancer patients.
@en
P2093
P356
P1476
A randomized study of ceftazid ...... infections in cancer patients.
@en
P2093
Fainstein V
Keating MJ
McCredie KB
Valdivieso M
P304
P356
10.1093/JAC/12.SUPPL_A.101
P407
P478
12 Suppl A
P577
1983-07-01T00:00:00Z